<--- Back to Details
First PageDocument Content
Prostate Cancer Foundation / Prostate cancer / Susan G. Komen for the Cure / American Association for Cancer Research / National Institutes of Health / Breast cancer / Breast cancer research stamp / Medicine / Oncology / Cancer organizations
Date: 2006-02-13 14:10:00
Prostate Cancer Foundation
Prostate cancer
Susan G. Komen for the Cure
American Association for Cancer Research
National Institutes of Health
Breast cancer
Breast cancer research stamp
Medicine
Oncology
Cancer organizations

Accomplishments layout.indd

Add to Reading List

Source URL: cdmrp.army.mil

Download Document from Source Website

File Size: 548,14 KB

Share Document on Facebook

Similar Documents

Journal of Machine Learning ResearchSubmitted 8/15; Revised 3/16; PublishedStructure-Leveraged Methods in Breast Cancer Risk Prediction

DocID: 1vq0d - View Document

Multicausality: Confounding - Assignment solutions 1. a. Reserpine is a risk factor. Overall, the incidence of breast cancer isper 100,000 women-years in reserpine users and 6.14 per 100,000 women-years in nonuser

DocID: 1vpNA - View Document

Frequently Asked Questions: Trainees seeking a PhD education in Cancer Biology or a related area with a focus on Breast Cancer Health Disparities. 1. What is the Komen Graduate Training in Disparities Research Grant (GT

DocID: 1voV1 - View Document

_____________________________________________________________ What to Do When Someone You Know Has Been Diagnosed with Breast Cancer [Last revised Mar 2014]

DocID: 1vlqg - View Document

Tangeretin inhibits the proliferation of human breast cancer cells via CYP1A1/CYP1B1 enzyme induction and CYP1A1/CYP1B1–mediated metabolism to the product 4′ hydroxy tangeretin

DocID: 1vl9e - View Document